France's Sanofi Scans China And Korea For Partnerships And Acquisitions As Part Of Global R&D Transformation
This article was originally published in PharmAsia News
Executive Summary
BEIJING - As part of a radical redesign of its worldwide research and development model, France's Sanofi-Aventis is searching for potential biotechnology partners in China and South Korea, according to Marc Cluzel, who heads Sanofi's global R&D operations
You may also be interested in...
Sanofi Looks To Build Stronger Alliances To Fuel R&D In Korea
Marking the conclusion of a 2009 MOU, Sanofi signed a letter of intent with the Korean government to take R&D investments to a new level.
Sanofi-Aventis Asia Pacific R&D Head Frank Jiang Sees Progress And Promise In Research Alliances Across China
BEIJING - As the Paris-headquartered Sanofi-Aventis expands its matrix of research alliances across China, this virtual R&D web is beginning to churn out tangible signs of progress and promise, according to a high-ranking Sanofi scientist based in China
Sanofi-Aventis Asia Pacific R&D Head Frank Jiang Sees Progress And Promise In Research Alliances Across China
BEIJING - As the Paris-headquartered Sanofi-Aventis expands its matrix of research alliances across China, this virtual R&D web is beginning to churn out tangible signs of progress and promise, according to a high-ranking Sanofi scientist based in China